Results 111 to 120 of about 18,175 (274)
The Effects of OnabotulinumtoxinA Treatment for Spasticity in Patients With Spinal Cord Injury: A Systematic Review and Meta-analysis [PDF]
Background and Purpose: Spasticity is a disabling complication of spinal cord injury (SCI). The administration of various medications is not satisfactory. Studies show the effects of onabotulinumtoxinA treatment for spasticity in patients with SCI.
Maryam Hosseini +6 more
doaj
Background Botulinum toxin-A (BTX-A) injection into muscle reduces muscular power and may prevent post-operative complication after orthognathic surgery.
Sung-Ho Shin +2 more
doaj +1 more source
“What Medical Management Should Be First Line for Bladder Storage Symptoms in NLUTD”—Pro Botox
ABSTRACT Objectives Neurogenic lower urinary tract dysfunction (NLUTD) severely impairs patient quality of life (QoL). While oral medications are often first‐line treatments, their high failure rates and side effects limit their effectiveness. Thus, we argue for the use of intravesical botulinum toxin A (BoNT‐A) injections as a first‐line alternative ...
Vada Furlan +2 more
wiley +1 more source
Introduction. Although incisional hernia is a rare condition in pediatric patients, it is relevant because of its possible complications and esthetic and functional impact. Case presentation.
Paula Andrea Quintero-Garzón +2 more
doaj +1 more source
Abstract Background Pain is often observed in patients with spasticity, but little is known about the relationship between pain and spasticity and the effectiveness of treating pain with botulinum toxins in these patients. Objective To explore onabotulinumtoxinA (onabotA) use and pain relief in patients with spasticity with pain at baseline.
Jörg Wissel +5 more
wiley +1 more source
Purpose To assess the response in spinal cord injured patients alternatively treated with different types and dosages of Botulinum neurotoxin type A (BoNT/A) over 15 years.
Giuseppe Lombardi +5 more
doaj +1 more source
Current evidence does not support the routine use of prophylactic antibiotics in uncomplicated anorectal procedures. However, the certainty of evidence is limited by small sample sizes, methodological heterogeneity, and limited number of available studies. Large‐scale randomized trials are required to strengthen this evidence base.
James Jin +3 more
wiley +1 more source
Background: Botulinum toxin type A is widely utilized for both therapeutic and aesthetic purposes, yet concerns regarding its immunogenicity have raised issues related to treatment failure and adverse reactions.
Kar Wai Alvin Lee +5 more
doaj +1 more source
ABSTRACT Background Implant‐based breast reconstruction (IBBR) is the most common method of breast reconstruction globally. Although the traditional approach places implants in a retropectoral position, pre‐pectoral reconstruction has recently gained popularity due to its improved aesthetic outcomes and lower capsular contracture (CC) rates.
Marco Bernini +14 more
wiley +1 more source
Retrograde Cricopharyngeal Dysfunction: Patient Characteristics and Outcomes in Australia
ABSTRACT Objective Retrograde cricopharyngeal dysfunction (RCPD) is characterised by an inability to burp. Typical first‐line management involves injection of Botulinum A toxin (BonT‐A) into the cricopharyngeus. We present our series of 109 RCPD patients.
Zhou Hao Leong +4 more
wiley +1 more source

